DAPTOMYCIN

DAPTOMYCIN was reported 9504 times

DAPTOMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MINIMUM INHIBITORY CONCENTRATION 24 0.7273
1 ABIOTROPHIA DEFECTIVA ENDOCARDITIS 4 0.4444
2 PROTOTHECOSIS 24 0.2553
3 AORTOENTERIC FISTULA 13 0.2031
4 EOSINOPHILIC PNEUMONIA ACUTE 149 0.1721
5 EOSINOPHILIC PNEUMONIA 487 0.1544
6 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 47 0.1521
7 BAND NEUTROPHIL COUNT DECREASED 7 0.1061
8 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 15 0.1056
9 INTRACRANIAL INFECTION 13 0.1040
10 CHIMERISM 8 0.0899
11 OSTEOMYELITIS FUNGAL 15 0.0898
12 MENINGITIS ENTEROCOCCAL 7 0.0886
13 ALVEOLAR LUNG DISEASE 15 0.0789
14 AUTOIMMUNE ANAEMIA 4 0.0727
15 ARTHRITIS FUNGAL 5 0.0694
16 ENTEROBACTER PNEUMONIA 10 0.0641
17 HYPEROXALURIA 11 0.0640
18 CATABOLIC STATE 4 0.0597
19 PROCALCITONIN DECREASED 4 0.0571
20 CANDIDA ENDOPHTHALMITIS 6 0.0492
21 GEOTRICHUM INFECTION 10 0.0474
22 HYPERSENSITIVITY PNEUMONITIS 53 0.0465
23 ASYMPTOMATIC BACTERIURIA 6 0.0441
24 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 7 0.0435
25 EOSINOPHILIC PUSTULAR FOLLICULITIS 4 0.0430
26 VANCOMYCIN INFUSION REACTION 16 0.0424
27 DISSEMINATED TRICHOSPORONOSIS 3 0.0417
28 SEPTIC PULMONARY EMBOLISM 8 0.0410
29 EOSINOPHILIC PLEURAL EFFUSION 12 0.0403
30 CORYNEBACTERIUM BACTERAEMIA 3 0.0353
31 SEPTIC ENCEPHALOPATHY 6 0.0349
32 SPLENIC EMBOLISM 4 0.0348
33 DRUG DISPENSED TO WRONG PATIENT 33 0.0346
34 HYPOPROTHROMBINAEMIA 10 0.0332
35 ACUTE INTERSTITIAL PNEUMONITIS 17 0.0326
36 CREATINE KINASE INCREASED 25 0.0325
37 DEVICE RELATED BACTERAEMIA 10 0.0323
38 CRYPTOCOCCAL CUTANEOUS INFECTION 5 0.0275
39 RETICULOCYTOPENIA 4 0.0274
40 PULMONARY EOSINOPHILIA 12 0.0262
41 STAPHYLOCOCCAL BACTERAEMIA 113 0.0260
42 BLADDER SPHINCTER ATONY 4 0.0258
43 FUSARIUM INFECTION 18 0.0257
44 DISSEMINATED ASPERGILLOSIS 12 0.0254
45 RECTAL PERFORATION 13 0.0241
46 DISSEMINATED MUCORMYCOSIS 9 0.0228
47 EOSINOPHILIA 387 0.0221
48 CRYSTALLURIA 12 0.0221
49 SYSTEMIC CANDIDA 55 0.0219
50 DIFFUSE ALVEOLAR DAMAGE 25 0.0217
51 CRYPTOCOCCAL FUNGAEMIA 3 0.0210
52 MEDIASTINITIS 12 0.0207
53 BLOOD CREATINE PHOSPHOKINASE 3 0.0205
54 PLASMABLASTIC LYMPHOMA 7 0.0196
55 URAEMIC ENCEPHALOPATHY 6 0.0192
56 GASTROINTESTINAL CANDIDIASIS 8 0.0191
57 URTICARIAL VASCULITIS 10 0.0189
58 SEPSIS SYNDROME 9 0.0179
59 HEPATIC CYTOLYSIS 227 0.0178
60 PNEUMONITIS CHEMICAL 6 0.0172
61 CHORIORETINITIS 11 0.0171
62 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 14 0.0170
63 CARDIAC VALVE VEGETATION 8 0.0165
64 BLOOD BETA-D-GLUCAN INCREASED 5 0.0163
65 TRANSFUSION-RELATED ACUTE LUNG INJURY 5 0.0162
66 MIXED ANXIETY AND DEPRESSIVE DISORDER 6 0.0162
67 RESPIRATORY GAS EXCHANGE DISORDER 6 0.0162
68 ENTEROCOCCAL INFECTION 78 0.0161
69 ENTEROCOCCAL SEPSIS 13 0.0160
70 ENTEROCOCCAL BACTERAEMIA 17 0.0160
71 PATHOGEN RESISTANCE 141 0.0155
72 NEPHRITIS ALLERGIC 6 0.0151
73 ALVEOLITIS ALLERGIC 15 0.0145
74 ENDOCARDITIS STAPHYLOCOCCAL 7 0.0142
75 INTERVERTEBRAL DISCITIS 26 0.0138
76 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 344 0.0134
77 AGRANULOCYTOSIS 246 0.0132
78 KOUNIS SYNDROME 29 0.0128
79 ENDOCARDITIS BACTERIAL 10 0.0127
80 GOUTY ARTHRITIS 10 0.0125
81 RED MAN SYNDROME 11 0.0125
82 HYPOPERFUSION 13 0.0124
83 MIXED LIVER INJURY 37 0.0123
84 UREAPLASMA INFECTION 5 0.0123
85 MYASTHENIA GRAVIS CRISIS 18 0.0121
86 HYPERCREATINAEMIA 4 0.0121
87 FUNGAL SEPSIS 10 0.0120
88 SEPTIC EMBOLUS 10 0.0120
89 CHOLURIA 4 0.0117
90 BLOOD CREATINE PHOSPHOKINASE INCREASED 329 0.0114
91 WRONG PATIENT RECEIVED PRODUCT 33 0.0113
92 CUTANEOUS VASCULITIS 41 0.0112
93 HAEMATOLOGICAL INFECTION 27 0.0110
94 PNEUMONIA NECROTISING 7 0.0108
95 ENTEROBACTER SEPSIS 4 0.0108
96 SKIN TEST POSITIVE 10 0.0107
97 THERAPEUTIC RESPONSE DELAYED 30 0.0107
98 DERMATOPHYTOSIS 3 0.0106
99 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 10 0.0106
100 HYPERGAMMAGLOBULINAEMIA 5 0.0103
101 CHOLESTATIC LIVER INJURY 23 0.0103
102 BACTERAEMIA 121 0.0102
103 FUNGAEMIA 16 0.0102
104 PARVOVIRUS INFECTION 4 0.0099
105 CHOLESTASIS 188 0.0098
106 ENDOCARDITIS 50 0.0097
107 ARTHRITIS BACTERIAL 40 0.0097
108 PNEUMONITIS 265 0.0097
109 LINEAR IGA DISEASE 16 0.0096
110 EPSTEIN-BARR VIRUS TEST POSITIVE 6 0.0095
111 BLOOD CULTURE POSITIVE 28 0.0093
112 CATHETER SITE RELATED REACTION 7 0.0093
113 RHABDOMYOLYSIS 389 0.0093
114 ENTEROCOCCUS TEST POSITIVE 6 0.0093
115 BRAIN ABSCESS 23 0.0091
116 CANDIDA SEPSIS 8 0.0089
117 SPINAL CORD DISORDER 14 0.0085
118 CYTOMEGALOVIRUS HEPATITIS 3 0.0085
119 GLOMERULAR FILTRATION RATE ABNORMAL 12 0.0085
120 KLEBSIELLA BACTERAEMIA 8 0.0084
121 NEUTROPENIC INFECTION 8 0.0084
122 LUNG OPACITY 22 0.0083
123 VISCERAL LEISHMANIASIS 6 0.0083
124 SOFT TISSUE INFECTION 15 0.0082
125 TOXIC EPIDERMAL NECROLYSIS 124 0.0082
126 ASPERGILLUS INFECTION 53 0.0081
127 PSOAS ABSCESS 5 0.0080
128 AXONAL NEUROPATHY 7 0.0080
129 PNEUMONIA PSEUDOMONAL 12 0.0078
130 STAPHYLOCOCCAL ABSCESS 5 0.0078
131 CHRONIC SPONTANEOUS URTICARIA 9 0.0078
132 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 60 0.0077
133 VASCULAR DEVICE INFECTION 35 0.0077
134 SYSTEMIC MYCOSIS 9 0.0077
135 MYOGLOBINURIA 4 0.0075
136 CORYNEBACTERIUM INFECTION 4 0.0075
137 RASH MACULO-PAPULAR 166 0.0075
138 STENOTROPHOMONAS INFECTION 10 0.0074
139 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 11 0.0072
140 PULMONARY TOXICITY 50 0.0071
141 CITROBACTER INFECTION 3 0.0070
142 VASCULITIS NECROTISING 5 0.0070
143 DEVICE RELATED SEPSIS 14 0.0069
144 MUCORMYCOSIS 18 0.0069
145 DIFFERENTIATION SYNDROME 5 0.0068
146 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 26 0.0068
147 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 3 0.0067
148 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
149 VASCULAR PURPURA 9 0.0064
150 MUSCLE ABSCESS 4 0.0064
151 CANDIDA INFECTION 107 0.0063
152 ESCHERICHIA SEPSIS 18 0.0062
153 C-REACTIVE PROTEIN DECREASED 4 0.0061
154 STAPHYLOCOCCAL SEPSIS 30 0.0061
155 NEUROLOGICAL DECOMPENSATION 14 0.0060
156 ARTERIOSPASM CORONARY 24 0.0060
157 AMAUROSIS 5 0.0059
158 MARROW HYPERPLASIA 4 0.0059
159 ORGANISING PNEUMONIA 29 0.0058
160 RASH MORBILLIFORM 16 0.0058
161 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
162 INTERSTITIAL LUNG DISEASE 275 0.0057
163 METABOLIC ALKALOSIS 9 0.0056
164 BACTERIAL DISEASE CARRIER 4 0.0055
165 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
166 DRUG RESISTANCE 139 0.0054
167 EOSINOPHIL COUNT INCREASED 45 0.0054
168 BRAIN STEM SYNDROME 4 0.0053
169 HUMAN HERPESVIRUS 6 INFECTION 10 0.0053
170 BLOOD FIBRINOGEN DECREASED 6 0.0053
171 MYOSITIS 47 0.0052
172 CAUDA EQUINA SYNDROME 4 0.0052
173 NEPHROGENIC DIABETES INSIPIDUS 6 0.0052
174 MULTIPLE-DRUG RESISTANCE 16 0.0052
175 HEPATITIS CHOLESTATIC 31 0.0051
176 HAEMODYNAMIC INSTABILITY 39 0.0051
177 EXTRADURAL ABSCESS 4 0.0051
178 IMPRISONMENT 9 0.0051
179 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 4 0.0051
180 OLIGURIA 31 0.0050
181 STRONGYLOIDIASIS 8 0.0049
182 SPUTUM CULTURE POSITIVE 4 0.0049
183 MULTIPLE ORGAN DYSFUNCTION SYNDROME 139 0.0049
184 ORAL MUCOSA EROSION 6 0.0049
185 LUNG INFILTRATION 43 0.0049
186 ERYTHRODERMIC PSORIASIS 4 0.0049
187 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 6 0.0048
188 PULMONARY SEPSIS 7 0.0048
189 HEPATITIS ACUTE 31 0.0048
190 WRONG PRODUCT ADMINISTERED 32 0.0047
191 SEIZURE LIKE PHENOMENA 8 0.0047
192 AUTOIMMUNE HAEMOLYTIC ANAEMIA 16 0.0047
193 LIVER ABSCESS 15 0.0046
194 STAPHYLOCOCCAL INFECTION 150 0.0045
195 NECROTISING FASCIITIS 16 0.0045
196 ARTHRITIS INFECTIVE 21 0.0045
197 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
198 HYPERAMMONAEMIA 22 0.0044
199 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 33 0.0044
200 RENAL TUBULAR NECROSIS 43 0.0044
201 TOXIC SKIN ERUPTION 44 0.0044
202 LUNG CONSOLIDATION 12 0.0043
203 H1N1 INFLUENZA 6 0.0043
204 ACUTE RESPIRATORY FAILURE 82 0.0043
205 JAUNDICE CHOLESTATIC 15 0.0042
206 SUSPECTED OFF LABEL USE 19 0.0042
207 ACUTE MYELOID LEUKAEMIA RECURRENT 9 0.0042
208 HYPERSENSITIVITY VASCULITIS 11 0.0042
209 PERICARDIAL HAEMORRHAGE 9 0.0041
210 ENCEPHALOPATHY 101 0.0041
211 CROSS SENSITIVITY REACTION 4 0.0041
212 PULMONARY VALVE INCOMPETENCE 6 0.0041
213 ACUTE KIDNEY INJURY 628 0.0041
214 CELL DEATH 8 0.0040
215 PSEUDOMONAL SEPSIS 7 0.0040
216 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
217 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
218 CATHETER RELATED INFECTION 4 0.0039
219 CYTOMEGALOVIRUS TEST POSITIVE 7 0.0039
220 MYOGLOBIN BLOOD INCREASED 6 0.0039
221 POTENTIATING DRUG INTERACTION 13 0.0039
222 ACUTE RESPIRATORY DISTRESS SYNDROME 68 0.0038
223 SINUS NODE DYSFUNCTION 7 0.0038
224 PNEUMONIA FUNGAL 15 0.0038
225 TUBULOINTERSTITIAL NEPHRITIS 71 0.0038
226 DYSENTERY 7 0.0038
227 KLEBSIELLA INFECTION 19 0.0038
228 DIABETES INSIPIDUS 9 0.0037
229 PSEUDOMONAS INFECTION 32 0.0037
230 HYPERLACTACIDAEMIA 10 0.0037
231 TOXOPLASMOSIS 4 0.0037
232 CATHETER SITE INFECTION 14 0.0037
233 HAEMORRHAGIC DISORDER 4 0.0037
234 ACINETOBACTER INFECTION 4 0.0037
235 OSTEOMYELITIS 66 0.0036
236 GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0036
237 INCISIONAL HERNIA 5 0.0036
238 SERUM SICKNESS 10 0.0036
239 SEPTIC SHOCK 156 0.0036
240 CULTURE URINE POSITIVE 5 0.0036
241 KLEBSIELLA SEPSIS 4 0.0035
242 HEPATOSPLENOMEGALY 9 0.0035
243 LICHENOID KERATOSIS 8 0.0035
244 FIXED ERUPTION 6 0.0035
245 CHOREA 6 0.0035
246 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 33 0.0035
247 MUCOSAL HAEMORRHAGE 4 0.0034
248 HYPERTRANSAMINASAEMIA 24 0.0034
249 HYPORESPONSIVE TO STIMULI 4 0.0034
250 PURPURA 30 0.0034
251 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0034
252 LIVEDO RETICULARIS 7 0.0033
253 PNEUMOMEDIASTINUM 6 0.0033
254 BONE MARROW DISORDER 10 0.0033
255 INFECTIOUS PLEURAL EFFUSION 5 0.0033
256 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
257 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
258 STREPTOCOCCAL INFECTION 18 0.0032
259 LEUKOPENIA 160 0.0032
260 HYPERAESTHESIA TEETH 4 0.0032
261 STEVENS-JOHNSON SYNDROME 70 0.0031
262 HAEMOLYTIC ANAEMIA 28 0.0031
263 HEPATOCELLULAR INJURY 44 0.0031
264 RESPIRATORY ALKALOSIS 5 0.0031
265 BICYTOPENIA 6 0.0031
266 PYODERMA GANGRENOSUM 11 0.0031
267 OXYGEN THERAPY 5 0.0030
268 LUNG DISORDER 148 0.0030
269 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 31 0.0030
270 HYPOVITAMINOSIS 4 0.0030
271 DRUG ERUPTION 53 0.0030
272 HIV INFECTION 9 0.0030
273 ENTEROBACTER INFECTION 5 0.0030
274 MYOCARDITIS 34 0.0030
275 DEVICE RELATED INFECTION 45 0.0029
276 DIVERTICULAR PERFORATION 6 0.0029
277 INTESTINAL ISCHAEMIA 16 0.0029
278 VASCULAR PSEUDOANEURYSM 5 0.0029
279 PANCYTOPENIA 160 0.0029
280 BACTERIAL INFECTION 53 0.0028
281 BRONCHOPULMONARY ASPERGILLOSIS 22 0.0028
282 GENERALISED OEDEMA 35 0.0028
283 FEBRILE BONE MARROW APLASIA 12 0.0028
284 ASTERIXIS 3 0.0028
285 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
286 NOSOCOMIAL INFECTION 6 0.0027
287 CLOSTRIDIUM TEST POSITIVE 6 0.0027
288 OTOTOXICITY 5 0.0027
289 PRODUCT LOT NUMBER ISSUE 6 0.0027
290 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 16 0.0027
291 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
292 MYCOBACTERIUM AVIUM COMPLEX INFECTION 7 0.0026
293 ADMINISTRATION SITE PAIN 3 0.0026
294 BLOOD CREATININE ABNORMAL 9 0.0026
295 TRAUMATIC LUNG INJURY 5 0.0026
296 THROMBOCYTOPENIA 288 0.0026
297 ATROPHY 5 0.0026
298 ESCHERICHIA INFECTION 21 0.0026
299 ESCHERICHIA BACTERAEMIA 6 0.0025
300 GASTROINTESTINAL STOMA COMPLICATION 4 0.0025
301 MULTI-ORGAN DISORDER 5 0.0025
302 BONE MARROW TOXICITY 3 0.0025
303 LONG QT SYNDROME 6 0.0025
304 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
305 CYTOMEGALOVIRUS INFECTION REACTIVATION 11 0.0025
306 IMMUNE-MEDIATED MYOCARDITIS 4 0.0025
307 GLOMERULONEPHRITIS 6 0.0024
308 RESPIRATORY DISTRESS 67 0.0024
309 PARAPLEGIA 7 0.0024
310 NEPHROPATHY TOXIC 27 0.0024
311 HEPATOTOXICITY 53 0.0024
312 OPTIC NEUROPATHY 5 0.0024
313 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
314 ABDOMINAL INFECTION 6 0.0023
315 CATHETER SITE PAIN 6 0.0023
316 APLASTIC ANAEMIA 12 0.0023
317 RESPIRATORY FAILURE 167 0.0023
318 FIBROSIS 7 0.0023
319 LEUKOCYTOSIS 41 0.0023
320 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
321 JUGULAR VEIN THROMBOSIS 4 0.0022
322 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
323 PSEUDOMEMBRANOUS COLITIS 5 0.0022
324 NEUTROPENIA 302 0.0022
325 IMMUNE THROMBOCYTOPENIA 10 0.0022
326 PNEUMONIA KLEBSIELLA 4 0.0022
327 TOXIC ENCEPHALOPATHY 11 0.0022
328 HEPATIC ENCEPHALOPATHY 20 0.0021
329 ABSCESS LIMB 9 0.0021
330 BONE MARROW TRANSPLANT 4 0.0021
331 FEBRILE NEUTROPENIA 139 0.0021
332 SUBCUTANEOUS ABSCESS 10 0.0021
333 HYPERKALAEMIA 73 0.0021
334 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 113 0.0021
335 NEUROTOXICITY 36 0.0021
336 HYPOXIA 72 0.0020
337 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
338 TRANSAMINASES INCREASED 45 0.0020
339 LACTIC ACIDOSIS 65 0.0020
340 HYPERCAPNIA 6 0.0020
341 CENTRAL VENOUS CATHETERISATION 6 0.0020
342 URINARY TRACT INFECTION BACTERIAL 5 0.0020
343 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
344 IMMUNE-MEDIATED HEPATITIS 4 0.0020
345 OSTEOLYSIS 4 0.0020
346 SKIN TOXICITY 11 0.0019
347 CYTOKINE RELEASE SYNDROME 39 0.0019
348 DERMATITIS BULLOUS 14 0.0019
349 DRUG LEVEL INCREASED 32 0.0019
350 BRAIN OEDEMA 24 0.0019
351 SEPSIS 211 0.0019
352 PERIPHERAL SENSORY NEUROPATHY 11 0.0019
353 MALNUTRITION 21 0.0019
354 CATHETER SITE ERYTHEMA 4 0.0019
355 HYPERPHOSPHATAEMIA 4 0.0019
356 CRYPTOCOCCOSIS 3 0.0018
357 CLONUS 5 0.0018
358 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
359 ABDOMINAL ABSCESS 8 0.0018
360 BLOOD CREATINE INCREASED 8 0.0018
361 HAEMODIALYSIS 15 0.0018
362 DRUG-INDUCED LIVER INJURY 56 0.0018
363 CHILLS 209 0.0018
364 ACUTE PULMONARY OEDEMA 10 0.0018
365 RENAL TUBULAR DISORDER 5 0.0018
366 SUBARACHNOID HAEMORRHAGE 18 0.0018
367 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
368 C-REACTIVE PROTEIN INCREASED 64 0.0018
369 PUSTULAR PSORIASIS 6 0.0017
370 FUNGAL SKIN INFECTION 7 0.0017
371 HYPOKINESIA 25 0.0017
372 BILIRUBIN CONJUGATED INCREASED 4 0.0017
373 HYPERTHERMIA 13 0.0017
374 HEPATIC FAILURE 51 0.0017
375 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
376 PRODUCT ADMINISTRATION ERROR 34 0.0017
377 ANAL ABSCESS 9 0.0017
378 METABOLIC ENCEPHALOPATHY 5 0.0017
379 ATELECTASIS 16 0.0017
380 TREATMENT FAILURE 137 0.0017
381 SHOCK 38 0.0017
382 OESOPHAGITIS 18 0.0016
383 THROMBOTIC MICROANGIOPATHY 16 0.0016
384 LIVER INJURY 40 0.0016
385 INFLAMMATORY MARKER INCREASED 8 0.0016
386 LOWER RESPIRATORY TRACT INFECTION 73 0.0016
387 ORAL CANDIDIASIS 21 0.0016
388 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
389 PNEUMONIA VIRAL 5 0.0016
390 HAEMOLYSIS 12 0.0016
391 PERIORBITAL OEDEMA 8 0.0015
392 COAGULOPATHY 25 0.0015
393 POSTOPERATIVE WOUND INFECTION 10 0.0015
394 CLOSTRIDIAL INFECTION 5 0.0015
395 HAEMATOTOXICITY 14 0.0015
396 DECUBITUS ULCER 12 0.0015
397 CYTOPENIA 18 0.0015
398 PRODUCT DISPENSING ERROR 32 0.0015
399 PLEURAL EFFUSION 89 0.0015
400 HYPERURICAEMIA 6 0.0015
401 LEFT VENTRICULAR FAILURE 5 0.0015
402 CAPILLARY LEAK SYNDROME 3 0.0014
403 IMMUNE-MEDIATED MYOSITIS 4 0.0014
404 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
405 DRUG INTERACTION 230 0.0014
406 PETECHIAE 15 0.0014
407 ENDOTRACHEAL INTUBATION 4 0.0014
408 SKIN INFECTION 16 0.0014
409 THERAPY NON-RESPONDER 64 0.0014
410 HYPERPYREXIA 6 0.0014
411 LYMPHOPENIA 20 0.0014
412 NEUTROPHILIA 8 0.0014
413 PURULENT DISCHARGE 6 0.0014
414 PYREXIA 481 0.0014
415 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
416 ADENOVIRUS INFECTION 4 0.0014
417 HALLUCINATION, VISUAL 29 0.0014
418 TRANSPLANT REJECTION 11 0.0014
419 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
420 FAILURE TO THRIVE 7 0.0013
421 HEPATIC NECROSIS 5 0.0013
422 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
423 PLATELET COUNT ABNORMAL 8 0.0013
424 THERAPY CHANGE 13 0.0013
425 ACUTE HEPATIC FAILURE 18 0.0013
426 ECCHYMOSIS 9 0.0013
427 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
428 BLOOD CREATININE INCREASED 85 0.0013
429 ENCEPHALITIS 9 0.0013
430 PRODUCT USE IN UNAPPROVED INDICATION 321 0.0013
431 HEPATITIS 33 0.0013
432 ERYTHEMA MULTIFORME 12 0.0013
433 METABOLIC ACIDOSIS 41 0.0013
434 MENTAL STATUS CHANGES 35 0.0013
435 HYPERBILIRUBINAEMIA 13 0.0013
436 AZOTAEMIA 5 0.0013
437 GRAFT VERSUS HOST DISEASE 9 0.0013
438 ENTERITIS 8 0.0012
439 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
440 SHOCK HAEMORRHAGIC 10 0.0012
441 BACTERIAL SEPSIS 4 0.0012
442 MULTI-ORGAN FAILURE 21 0.0012
443 HYPERVOLAEMIA 6 0.0012
444 PERICARDIAL EFFUSION 28 0.0012
445 RENAL IMPAIRMENT 101 0.0012
446 PNEUMONIA BACTERIAL 11 0.0012
447 NEPHRITIS 4 0.0012
448 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
449 TACHYPNOEA 16 0.0012
450 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
451 PHLEBITIS 6 0.0012
452 AORTIC ARTERIOSCLEROSIS 3 0.0012
453 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
454 UNRESPONSIVE TO STIMULI 30 0.0012
455 SKIN NECROSIS 6 0.0012
456 COMPARTMENT SYNDROME 3 0.0011
457 LUNG TRANSPLANT 4 0.0011
458 PHARYNGEAL SWELLING 11 0.0011
459 SKIN WEEPING 4 0.0011
460 GASTRIC ULCER 21 0.0011
461 COVID-19 PNEUMONIA 13 0.0011
462 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
463 MYOCLONUS 13 0.0011
464 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
465 DIALYSIS 15 0.0011
466 CELLULITIS 53 0.0011
467 SKIN MASS 7 0.0010
468 ANAPHYLACTIC SHOCK 27 0.0010
469 RENAL FAILURE ACUTE 44 0.0010
470 VASCULITIS 12 0.0010
471 RHINOVIRUS INFECTION 4 0.0010
472 PULMONARY OEDEMA 46 0.0010
473 EXPIRED PRODUCT ADMINISTERED 34 0.0010
474 CYTOMEGALOVIRUS INFECTION 17 0.0010
475 PULMONARY HAEMORRHAGE 8 0.0010
476 VENOUS THROMBOSIS 4 0.0010
477 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
478 HAEMATOCRIT DECREASED 20 0.0010
479 CREPITATIONS 3 0.0010
480 BRAIN HERNIATION 3 0.0010
481 DERMATITIS EXFOLIATIVE 5 0.0010
482 SMALL INTESTINAL OBSTRUCTION 12 0.0010
483 HYPERCALCAEMIA 12 0.0010
484 NEPHROPATHY 9 0.0010
485 ACUTE MYELOID LEUKAEMIA 15 0.0010
486 ANGINA PECTORIS 27 0.0009
487 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
488 ANURIA 8 0.0009
489 HEPATOMEGALY 9 0.0009
490 URINE OUTPUT DECREASED 8 0.0009
491 WHITE BLOOD CELL COUNT INCREASED 35 0.0009
492 RENAL FAILURE 121 0.0009
493 RED BLOOD CELL SEDIMENTATION RATE INCREASED 10 0.0009
494 BK VIRUS INFECTION 3 0.0009
495 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
496 DRUG LEVEL DECREASED 9 0.0009
497 PERONEAL NERVE PALSY 5 0.0009
498 ABSCESS 14 0.0009
499 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
500 CARDIAC VALVE DISEASE 5 0.0009
501 NEUROLOGICAL SYMPTOM 5 0.0009
502 APLASIA PURE RED CELL 3 0.0009
503 ENTEROCOLITIS 5 0.0009
504 NEPHROGENIC ANAEMIA 4 0.0009
505 ELECTROLYTE IMBALANCE 10 0.0009
506 HAEMOPTYSIS 24 0.0009
507 RIGHT VENTRICULAR FAILURE 6 0.0009
508 UMBILICAL HERNIA 4 0.0009
509 TACHYCARDIA 76 0.0009
510 SKIN REACTION 12 0.0009
511 ARTERIOSCLEROSIS 8 0.0008
512 ACUTE MYOCARDIAL INFARCTION 25 0.0008
513 BRONCHOSPASM 12 0.0008
514 BONE LESION 3 0.0008
515 FACE OEDEMA 14 0.0008
516 FACIAL PARALYSIS 7 0.0008
517 DENTAL CARIES 9 0.0008
518 AMYLASE INCREASED 3 0.0008
519 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
520 NEUTROPHIL COUNT DECREASED 33 0.0008
521 PULMONARY MASS 12 0.0008
522 ABDOMINAL TENDERNESS 4 0.0008
523 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
524 OFF LABEL USE 703 0.0008
525 HYPERNATRAEMIA 4 0.0008
526 OXYGEN SATURATION DECREASED 45 0.0008
527 LIVER FUNCTION TEST ABNORMAL 23 0.0008
528 TROPONIN INCREASED 6 0.0008
529 PATHOLOGICAL FRACTURE 4 0.0008
530 NEURALGIA 19 0.0008
531 RENAL FAILURE CHRONIC 6 0.0008
532 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
533 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
534 RASH PRURITIC 42 0.0008
535 SINUS TACHYCARDIA 11 0.0008
536 PERITONITIS 16 0.0008
537 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
538 RASH ERYTHEMATOUS 36 0.0008
539 ANAEMIA 143 0.0007
540 CANDIDIASIS 3 0.0007
541 MYASTHENIA GRAVIS 6 0.0007
542 POST PROCEDURAL INFECTION 6 0.0007
543 PULMONARY FIBROSIS 14 0.0007
544 TREMOR 121 0.0007
545 CEREBRAL HAEMORRHAGE 26 0.0007
546 JOINT EFFUSION 5 0.0007
547 EMBOLISM 6 0.0007
548 DELIRIUM 25 0.0007
549 FUNGAL INFECTION 24 0.0007
550 BLOOD UREA INCREASED 12 0.0007
551 EXTRASYSTOLES 5 0.0007
552 END STAGE RENAL DISEASE 13 0.0007
553 SKIN PLAQUE 6 0.0007
554 MITRAL VALVE INCOMPETENCE 8 0.0007
555 ANAPHYLACTIC REACTION 39 0.0007
556 GENERALISED ERYTHEMA 4 0.0007
557 CARDIAC ARREST 58 0.0007
558 NEUTROPENIC SEPSIS 5 0.0007
559 SKIN HYPERPIGMENTATION 6 0.0007
560 HYPOTENSION 140 0.0007
561 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
562 CARDIOGENIC SHOCK 10 0.0007
563 PNEUMOTHORAX 11 0.0007
564 HYPOKALAEMIA 32 0.0007
565 BONE MARROW FAILURE 14 0.0007
566 PRODUCT PRESCRIBING ISSUE 15 0.0007
567 ATRIAL FIBRILLATION 67 0.0007
568 TOOTH ABSCESS 7 0.0007
569 RASH PUSTULAR 5 0.0007
570 CONFUSIONAL STATE 110 0.0007
571 INFECTION 98 0.0007
572 HYPOPHOSPHATAEMIA 5 0.0007
573 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
574 CONDITION AGGRAVATED 204 0.0007
575 FOLLICULITIS 7 0.0007
576 PANCREATITIS ACUTE 15 0.0007
577 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
578 SUDDEN DEATH 7 0.0007
579 RASH GENERALISED 17 0.0007
580 SKIN LESION 18 0.0007
581 HAEMATOMA 17 0.0007
582 RESTLESSNESS 24 0.0007
583 RESPIRATORY TRACT INFECTION 17 0.0007
584 LIPASE INCREASED 5 0.0007
585 PNEUMONIA 211 0.0007
586 RASH 282 0.0006
587 DERMATITIS ALLERGIC 8 0.0006
588 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
589 TRICUSPID VALVE INCOMPETENCE 5 0.0006
590 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
591 APHAGIA 3 0.0006
592 SINUS BRADYCARDIA 6 0.0006
593 PLATELET COUNT DECREASED 66 0.0006
594 SKIN ULCER 16 0.0006
595 FLUID OVERLOAD 9 0.0006
596 HIATUS HERNIA 8 0.0006
597 ASCITES 18 0.0006
598 BREATH SOUNDS ABNORMAL 3 0.0006
599 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
600 ADVERSE REACTION 8 0.0006
601 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
602 LIP SWELLING 20 0.0006
603 HYPOTHERMIA 6 0.0006
604 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
605 AMMONIA INCREASED 3 0.0006
606 ANGIOEDEMA 26 0.0006
607 CHOLECYSTITIS 7 0.0006
608 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
609 BLOOD PRESSURE FLUCTUATION 14 0.0006
610 DRUG INEFFECTIVE 768 0.0006
611 RASH PAPULAR 13 0.0006
612 LOCALISED INFECTION 14 0.0006
613 NERVOUS SYSTEM DISORDER 18 0.0006
614 HYPOMAGNESAEMIA 8 0.0006
615 OEDEMA 31 0.0006
616 MYALGIA 97 0.0006
617 BLOOD LACTIC ACID INCREASED 3 0.0006
618 PAPULE 4 0.0006
619 HAEMOGLOBIN DECREASED 58 0.0006
620 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
621 MYELOSUPPRESSION 20 0.0006
622 BLOOD BILIRUBIN INCREASED 15 0.0006
623 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
624 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
625 BLISTER 31 0.0006
626 HYPOPHAGIA 14 0.0005
627 CARDIOMYOPATHY 8 0.0005
628 HYPERTENSIVE CRISIS 6 0.0005
629 LYMPHADENOPATHY 19 0.0005
630 HAEMORRHAGE INTRACRANIAL 8 0.0005
631 MUCOSAL INFLAMMATION 14 0.0005
632 FISTULA 6 0.0005
633 FLANK PAIN 5 0.0005
634 HYPONATRAEMIA 30 0.0005
635 HEART RATE IRREGULAR 12 0.0005
636 PULMONARY CONGESTION 7 0.0005
637 REBOUND EFFECT 6 0.0005
638 HEPATIC ENZYME INCREASED 36 0.0005
639 CARDIO-RESPIRATORY ARREST 22 0.0005
640 DERMATITIS 11 0.0005
641 DISEASE PROGRESSION 62 0.0005
642 ACIDOSIS 4 0.0005
643 SEROTONIN SYNDROME 10 0.0005
644 PNEUMONIA ASPIRATION 13 0.0005
645 LIVER FUNCTION TEST INCREASED 11 0.0005
646 SWOLLEN TONGUE 16 0.0005
647 SKIN EXFOLIATION 43 0.0005
648 RENAL INJURY 15 0.0005
649 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
650 FEELING COLD 14 0.0005
651 MUSCLE RIGIDITY 6 0.0005
652 URTICARIA 84 0.0005
653 PERITONITIS BACTERIAL 5 0.0005
654 MUSCLE DISORDER 4 0.0005
655 BLOOD POTASSIUM INCREASED 8 0.0005
656 NO THERAPEUTIC RESPONSE 6 0.0005
657 ORAL PAIN 11 0.0005
658 POLYURIA 4 0.0005
659 RASH MACULAR 17 0.0005
660 PHOTOSENSITIVITY REACTION 8 0.0005
661 SPINAL COMPRESSION FRACTURE 4 0.0005
662 HEPATIC STEATOSIS 9 0.0005
663 HEPATIC FUNCTION ABNORMAL 18 0.0005
664 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
665 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
666 INFUSION SITE ERYTHEMA 4 0.0005
667 CIRCULATORY COLLAPSE 8 0.0005
668 HAEMATURIA 16 0.0005
669 PRESCRIBED OVERDOSE 9 0.0005
670 MYOPATHY 4 0.0005
671 PULMONARY EMBOLISM 44 0.0005
672 SPINAL OSTEOARTHRITIS 4 0.0005
673 TUMOUR LYSIS SYNDROME 4 0.0005
674 PANCREATITIS 24 0.0005
675 IMMUNOSUPPRESSION 4 0.0005
676 APPETITE DISORDER 3 0.0005
677 RESPIRATORY RATE INCREASED 4 0.0005
678 VENTRICULAR FIBRILLATION 5 0.0004
679 CARDIAC FAILURE 36 0.0004
680 INTESTINAL PERFORATION 5 0.0004
681 INFUSION RELATED REACTION 29 0.0004
682 LETHARGY 25 0.0004
683 CHRONIC KIDNEY DISEASE 33 0.0004
684 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
685 ERYTHEMA 88 0.0004
686 SPLENOMEGALY 5 0.0004
687 DYSARTHRIA 16 0.0004
688 LEUKAEMIA 4 0.0004
689 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
690 ATAXIA 5 0.0004
691 ECZEMA 22 0.0004
692 OEDEMA PERIPHERAL 51 0.0004
693 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
694 POLYNEUROPATHY 5 0.0004
695 PERICARDITIS 7 0.0004
696 BURSITIS 5 0.0004
697 DYSPNOEA 233 0.0004
698 AUTOIMMUNE DISORDER 4 0.0004
699 VITAMIN D DEFICIENCY 4 0.0004
700 CEREBRAL INFARCTION 10 0.0004
701 PSYCHOTIC DISORDER 12 0.0004
702 CEREBRAL DISORDER 3 0.0004
703 PALLOR 11 0.0004
704 PRODUCT STORAGE ERROR 35 0.0004
705 EMPHYSEMA 4 0.0004
706 RECTAL HAEMORRHAGE 17 0.0004
707 PHARYNGEAL OEDEMA 6 0.0004
708 LYMPHOMA 6 0.0004
709 LIMB DISCOMFORT 12 0.0004
710 EJECTION FRACTION DECREASED 6 0.0004
711 VENTRICULAR EXTRASYSTOLES 4 0.0004
712 HYPERSENSITIVITY 71 0.0004
713 TRANSFUSION 4 0.0004
714 GENERAL PHYSICAL HEALTH DETERIORATION 44 0.0004
715 NEUROPATHY PERIPHERAL 36 0.0004
716 BLOOD ALBUMIN DECREASED 3 0.0004
717 ATRIAL FLUTTER 3 0.0004
718 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
719 HEPATIC CIRRHOSIS 7 0.0004
720 HYPOCALCAEMIA 7 0.0004
721 THROAT TIGHTNESS 10 0.0004
722 COLITIS 14 0.0004
723 WOUND INFECTION 4 0.0004
724 ASPIRATION 4 0.0004
725 EPILEPSY 11 0.0004
726 BONE PAIN 21 0.0004
727 DEVICE OCCLUSION 5 0.0004
728 STATUS EPILEPTICUS 4 0.0004
729 DISORIENTATION 14 0.0004
730 DERMATITIS CONTACT 4 0.0004
731 THERAPY CESSATION 18 0.0004
732 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
733 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
734 SUBDURAL HAEMATOMA 5 0.0003
735 CARDIAC OPERATION 3 0.0003
736 BLOOD MAGNESIUM DECREASED 3 0.0003
737 EPISTAXIS 26 0.0003
738 PRURITUS 133 0.0003
739 CHEST PAIN 64 0.0003
740 INTENTIONAL PRODUCT MISUSE 30 0.0003
741 LIVER DISORDER 15 0.0003
742 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
743 PULMONARY HYPERTENSION 7 0.0003
744 PRODUCT PRESCRIBING ERROR 8 0.0003
745 HYPERLIPIDAEMIA 4 0.0003
746 RESPIRATORY DISORDER 10 0.0003
747 HALLUCINATION 25 0.0003
748 LIMB INJURY 9 0.0003
749 TENDON RUPTURE 4 0.0003
750 OSTEONECROSIS OF JAW 8 0.0003
751 TENDONITIS 5 0.0003
752 LUNG INFECTION 5 0.0003
753 DEFORMITY 3 0.0003
754 THERAPY PARTIAL RESPONDER 5 0.0003
755 TOXICITY TO VARIOUS AGENTS 54 0.0003
756 MELAENA 7 0.0003
757 CYANOSIS 5 0.0003
758 MUSCULOSKELETAL DISORDER 6 0.0003
759 SEIZURE 36 0.0003
760 PRODUCT USE ISSUE 58 0.0003
761 PRODUCT AVAILABILITY ISSUE 7 0.0003
762 ASTHENIA 115 0.0003
763 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
764 HYPERGLYCAEMIA 11 0.0003
765 BRAIN INJURY 3 0.0003
766 JAUNDICE 8 0.0003
767 BODY TEMPERATURE INCREASED 6 0.0003
768 COMA 14 0.0003
769 DRUG TOXICITY 4 0.0003
770 RESPIRATORY ARREST 8 0.0003
771 HYPOGLYCAEMIA 14 0.0003
772 CARDIAC FAILURE CONGESTIVE 23 0.0003
773 LYMPHOCYTE COUNT DECREASED 5 0.0003
774 PAIN IN JAW 8 0.0003
775 DEEP VEIN THROMBOSIS 18 0.0003
776 WHEEZING 16 0.0003
777 URINARY TRACT INFECTION 46 0.0003
778 SNEEZING 6 0.0003
779 MALAISE 117 0.0003
780 ANHEDONIA 7 0.0003
781 FEELING HOT 16 0.0003
782 MUSCULOSKELETAL CHEST PAIN 4 0.0003
783 DELUSION 4 0.0003
784 BURNING SENSATION 18 0.0003
785 PREMATURE DELIVERY 4 0.0003
786 WOUND 7 0.0003
787 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
788 COUGH 70 0.0002
789 ABDOMINAL PAIN 58 0.0002
790 ADRENAL INSUFFICIENCY 3 0.0002
791 GASTROINTESTINAL DISORDER 22 0.0002
792 CARDIOMEGALY 3 0.0002
793 NAUSEA 193 0.0002
794 METASTASES TO BONE 4 0.0002
795 IMPAIRED HEALING 8 0.0002
796 TOOTH LOSS 5 0.0002
797 BLOOD PRESSURE DECREASED 16 0.0002
798 DYSSTASIA 7 0.0002
799 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
800 KNEE ARTHROPLASTY 5 0.0002
801 SCAR 4 0.0002
802 DEHYDRATION 31 0.0002
803 ARRHYTHMIA 11 0.0002
804 DYSPHAGIA 22 0.0002
805 NEOPLASM PROGRESSION 8 0.0002
806 AMENORRHOEA 4 0.0002
807 METASTASES TO LIVER 4 0.0002
808 BRADYCARDIA 12 0.0002
809 FREQUENT BOWEL MOVEMENTS 6 0.0002
810 TOOTHACHE 4 0.0002
811 MUSCULAR WEAKNESS 25 0.0002
812 BACK PAIN 51 0.0002
813 BONE DISORDER 4 0.0002
814 NIGHT SWEATS 7 0.0002
815 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
816 CHOLELITHIASIS 7 0.0002
817 OVERDOSE 46 0.0002
818 INFLAMMATION 11 0.0002
819 OSTEONECROSIS 7 0.0002
820 SLEEP DISORDER 15 0.0002
821 DYSPNOEA EXERTIONAL 8 0.0002
822 UNEVALUABLE EVENT 16 0.0002
823 COVID-19 37 0.0002
824 HAEMORRHAGE 22 0.0002
825 PROTEINURIA 4 0.0002
826 DISEASE RECURRENCE 10 0.0002
827 SPEECH DISORDER 11 0.0002
828 HYPERHIDROSIS 27 0.0002
829 PRODUCTIVE COUGH 10 0.0002
830 VOMITING 98 0.0002
831 EAR PAIN 4 0.0002
832 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
833 APHASIA 6 0.0002
834 DIARRHOEA 128 0.0002
835 SKIN DISCOLOURATION 9 0.0002
836 DRUG ADMINISTRATION ERROR 6 0.0002
837 CHEST DISCOMFORT 20 0.0002
838 PRODUCT PREPARATION ERROR 4 0.0002
839 DEATH 167 0.0002
840 NO ADVERSE EVENT 35 0.0002
841 DEAFNESS 5 0.0002
842 GASTRITIS 5 0.0002
843 DECREASED APPETITE 44 0.0002
844 FEAR 5 0.0002
845 SKIN CANCER 4 0.0002
846 DISTURBANCE IN ATTENTION 10 0.0002
847 PRURITUS GENERALISED 4 0.0002
848 SWELLING FACE 12 0.0002
849 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
850 TREATMENT NONCOMPLIANCE 10 0.0002
851 STOMATITIS 11 0.0002
852 SYNCOPE 18 0.0002
853 SKIN DISORDER 6 0.0002
854 HYPERTENSION 38 0.0002
855 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
856 ARTHRALGIA 73 0.0002
857 JOINT SWELLING 21 0.0002
858 RENAL DISORDER 8 0.0002
859 PARAESTHESIA 27 0.0002
860 HEART RATE INCREASED 17 0.0002
861 URINARY INCONTINENCE 5 0.0002
862 DIABETIC KETOACIDOSIS 4 0.0002
863 ACCIDENTAL OVERDOSE 6 0.0002
864 EYE SWELLING 6 0.0002
865 NECK PAIN 9 0.0002
866 AGEUSIA 4 0.0002
867 SWELLING 15 0.0002
868 BLOOD URINE PRESENT 3 0.0002
869 HAEMATEMESIS 4 0.0002
870 CYSTITIS 5 0.0002
871 HERPES ZOSTER 9 0.0002
872 HYPOTHYROIDISM 5 0.0002
873 CHOKING 3 0.0002
874 AGITATION 11 0.0001
875 GAIT INABILITY 5 0.0001
876 FATIGUE 115 0.0001
877 DYSKINESIA 6 0.0001
878 VISUAL IMPAIRMENT 18 0.0001
879 EXPOSURE DURING PREGNANCY 9 0.0001
880 BLOOD PRESSURE INCREASED 22 0.0001
881 ABDOMINAL DISTENSION 15 0.0001
882 HEART RATE DECREASED 5 0.0001
883 LOSS OF CONSCIOUSNESS 18 0.0001
884 OROPHARYNGEAL PAIN 13 0.0001
885 HYPERSOMNIA 4 0.0001
886 PAIN 84 0.0001
887 GAIT DISTURBANCE 26 0.0001
888 LABORATORY TEST ABNORMAL 4 0.0001
889 ADVERSE DRUG REACTION 12 0.0001
890 CHROMATURIA 3 0.0001
891 INTESTINAL OBSTRUCTION 5 0.0001
892 CORONARY ARTERY DISEASE 4 0.0001
893 MYOCARDIAL INFARCTION 23 0.0001
894 DIABETES MELLITUS 10 0.0001
895 TINNITUS 6 0.0001
896 FALL 43 0.0001
897 INJURY 9 0.0001
898 INCORRECT DOSE ADMINISTERED 29 0.0001
899 PERIPHERAL SWELLING 19 0.0001
900 WEIGHT DECREASED 34 0.0001
901 ABASIA 3 0.0001
902 DYSPHONIA 7 0.0001
903 TYPE 2 DIABETES MELLITUS 4 0.0001
904 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
905 CARDIOVASCULAR DISORDER 3 0.0001
906 OSTEOARTHRITIS 5 0.0001
907 HOSPITALISATION 18 0.0001
908 DIZZINESS 58 0.0001
909 SUICIDE ATTEMPT 7 0.0001
910 MUSCULOSKELETAL PAIN 6 0.0001
911 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
912 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
913 THROMBOSIS 9 0.0001
914 SKIN IRRITATION 5 0.0001
915 BRONCHITIS 8 0.0001
916 MEDICATION ERROR 6 0.0001
917 DEMENTIA 3 0.0001
918 COGNITIVE DISORDER 5 0.0001
919 CONVULSION 6 0.0001
920 SOMNOLENCE 21 0.0001
921 PLASMA CELL MYELOMA 4 0.0001
922 SURGERY 6 0.0001
923 ABDOMINAL DISCOMFORT 17 0.0001
924 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
925 CONSTIPATION 22 0.0001
926 CEREBROVASCULAR ACCIDENT 17 0.0001
927 BLOOD POTASSIUM DECREASED 3 0.0001
928 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
929 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
930 HEADACHE 62 0.0001
931 EXTRA DOSE ADMINISTERED 4 0.0001
932 DISCOMFORT 6 0.0001
933 SUICIDAL IDEATION 9 0.0001
934 FLUID RETENTION 5 0.0001
935 MUSCLE SPASMS 18 0.0001
936 THERAPY INTERRUPTED 7 0.0001
937 ADVERSE EVENT 9 0.0001
938 DRUG INTOLERANCE 9 0.0001
939 MENTAL DISORDER 4 0.0001
940 EMOTIONAL DISTRESS 11 0.0001
941 ARTHROPATHY 5 0.0001
942 PAIN IN EXTREMITY 26 0.0001
943 NEPHROLITHIASIS 4 0.0001
944 INSOMNIA 23 0.0001
945 ANXIETY 24 0.0001
946 OCULAR HYPERAEMIA 4 0.0001
947 CONTUSION 8 0.0001
948 ABDOMINAL PAIN UPPER 17 0.0001
949 DYSPEPSIA 8 0.0001
950 SINUSITIS 8 0.0001
951 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
952 CARDIAC DISORDER 7 0.0001
953 BLOOD GLUCOSE INCREASED 14 0.0001
954 DRUG EFFECT DECREASED 4 0.0001
955 DEVICE BREAKAGE 3 0.0001
956 HYPOAESTHESIA 11 0.0001
957 VISION BLURRED 10 0.0001
958 MEMORY IMPAIRMENT 10 0.0001
959 HAEMATOCHEZIA 4 0.0001
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
961 MOBILITY DECREASED 5 0.0001
962 BALANCE DISORDER 6 0.0001
963 FLUSHING 7 0.0001
964 PALPITATIONS 8 0.0001
965 ILLNESS 7 0.0001
966 COLITIS ULCERATIVE 3 0.0001
967 WEIGHT INCREASED 15 0.0001
968 PRODUCT QUALITY ISSUE 9 0.0001
969 DEPRESSION 15 0.0001
970 ILL-DEFINED DISORDER 4 0.0001
971 VERTIGO 4 0.0001
972 NASOPHARYNGITIS 12 0.0001
973 BLOOD CHOLESTEROL INCREASED 3 0.0001
974 INFLUENZA 7 0.0001
975 ASTHMA 7 0.0001
976 ALOPECIA 11 0.0001
977 DYSGEUSIA 4 0.0001
978 HOT FLUSH 4 0.0001
979 ARTHRITIS 4 0.0001
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
981 DRY MOUTH 4 0.0000
982 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
983 INJECTION SITE ERYTHEMA 6 0.0000
984 DRY SKIN 6 0.0000
985 PRODUCT DOSE OMISSION ISSUE 13 0.0000
986 DEVICE MALFUNCTION 3 0.0000
987 MIGRAINE 4 0.0000
988 FEELING ABNORMAL 10 0.0000
989 ACNE 3 0.0000
990 PSORIASIS 5 0.0000
991 BREAST CANCER 3 0.0000
992 DRUG DOSE OMISSION 5 0.0000
993 INJECTION SITE PAIN 7 0.0000